CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 115 filers reported holding CYTOMX THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 1.75 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $56,000 | -79.2% | 30,340 | -6.4% | 0.00% | -95.0% |
| Q4 2019 | $269,000 | +74.7% | 32,403 | +55.5% | 0.08% | +40.4% |
| Q3 2019 | $154,000 | -72.1% | 20,843 | -57.6% | 0.06% | -72.1% |
| Q2 2019 | $551,000 | -51.7% | 49,123 | -35.0% | 0.20% | -35.8% |
| Q4 2018 | $1,141,000 | -7.7% | 75,586 | +13.1% | 0.32% | +19.1% |
| Q3 2018 | $1,236,000 | +149.7% | 66,809 | +208.6% | 0.27% | +159.2% |
| Q2 2018 | $495,000 | -18.3% | 21,650 | +1.6% | 0.10% | -12.0% |
| Q1 2018 | $606,000 | -44.0% | 21,300 | -58.4% | 0.12% | -54.1% |
| Q4 2017 | $1,082,000 | +29.9% | 51,233 | +11.7% | 0.26% | +34.2% |
| Q3 2017 | $833,000 | +54.5% | 45,853 | +31.8% | 0.19% | +25.8% |
| Q2 2017 | $539,000 | – | 34,803 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Burrage Capital Management LLC | 476,110 | $3,956,000 | 2.65% |
| MPM BioImpact LLC | 855,437 | $7,109,000 | 2.52% |
| Exane Asset Management | 87,876 | $730,250,000 | 0.90% |
| Congress Park Capital LLC | 94,661 | $787,000 | 0.58% |
| Perceptive Advisors | 3,253,923 | $27,040,000 | 0.54% |
| BVF INC/IL | 766,148 | $6,367,000 | 0.48% |
| RTW INVESTMENTS, LP | 1,039,593 | $8,639,000 | 0.33% |
| EcoR1 Capital, LLC | 410,000 | $3,407,000 | 0.31% |
| DAFNA Capital Management LLC | 100,000 | $831,000 | 0.28% |
| HARBOURVEST PARTNERS LLC | 79,193 | $658,000 | 0.27% |